Takeda Pharmaceutical News and Activities

Presence

Takeda Pharmaceutical develops and sells prescription medicines, vaccines, and plasma therapies. It serves patients, hospitals, and healthcare providers in Japan and international markets.

Takeda Pharmaceutical products and services overview:

Prescription medicines
Vaccines
Plasma therapies
Rare disease treatments
Oncology treatments
Gastrointestinal treatments

Revenue: ~$28 billion

Employees: 50,000

Headquarters: Tokyo, Japan

Takeda Pharmaceutical is one of the...

Takeda Pharmaceutical is a company listed under the stock ticker 4502 (JP).

Takeda Pharmaceutical has a direct presence in 19 countries.

Takeda Pharmaceutical has 20 subsidiaries including Takeda Americas, Takeda APAC and Takeda Australia.

They are in:

Pharmaceuticals95%
Fund5%

Executives

View the org chart displaying its 148 main executives

Most searched biographies at Takeda Pharmaceutical

Popular executive movements at Takeda Pharmaceutical

Christophe Weber, Chief Executive Officer, has left the company (posted on June 8 2026).
Julie Kim, who was Interim Head, Global Portfolio Division, is promoted to Chief Executive Officer (posted on June 8 2026).
Thomas Wozniewski, Global Manufacturing and Supply Officer, has left the company (posted on April 8 2026).

Click here to view some more movements at Takeda Pharmaceutical

Create your alert
to follow the executive moves at Takeda Pharmaceutical.